Ghisallo Capital Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Ghisallo Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$20.12 - $35.09 $402,400 - $701,800	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$23.84 - $32.03 $4.89 Million - $6.57 Million	-205,000 Reduced 91.11%	20,000 $607,000
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $6.54 Million - $8.74 Million	225,000 New	225,000 $6.54 Million

445K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $45.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ghisallo Capital Management LLC with notifications on news.